What's in LEO PHARMA AS's pipeline?

LEO PHARMA AS has 2 drugs in our index: 2 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with LEO PHARMA AS's portfolio?

Top competitors by shared drug class: ELI LILLY AND CO, Eli Lilly And Co.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/leo-pharma-as.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

LEO PHARMA AS — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

LEO PHARMA AS pipeline: 2 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Adbry	TRALOKINUMAB	marketed	Interleukin-13 Antagonist [EPC]	Interleukin-13	Immunology	2021-01-01
Azelex	AZELAIC ACID	marketed	azelaic acid	3-oxo-5-alpha-steroid 4-dehydrogenase 2	Dermatology	1995-01-01

Therapeutic area mix

Dermatology · 1
Immunology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

2027-09-18 — Azelex · 7700076 · Formulation · US
2027-10-18 — Azelex · 10117812 · Formulation · US
2027-12-08 — Azelex · 9265725 · Formulation · US
2029-02-28 — Azelex · 9211259 · Method of Use · US

Competitive overlap (companies sharing drug classes)

ELI LILLY AND CO · 1 shared drug class
Eli Lilly And Co · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for LEO PHARMA AS:

Cite this brief

Drug Landscape (2026). LEO PHARMA AS — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/leo-pharma-as. Accessed 2026-06-10.